Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL
Autor: | Christopher Beierschmitt, Donté Alexander Stevens, Swetha Mahesula, Miles R Corley, John Salogiannis, Brian V Tsu, Bryant Cao, Andrew P Ryan, Hiroyuki Hakozawki, Samara L Reck-Peterson, Matthew D Daugherty |
---|---|
Rok vydání: | 2022 |
Předmět: |
infectious disease
innate antiviral immunity Virus Replication Antiviral Agents General Biochemistry Genetics and Molecular Biology immunology Vaccine Related Biodefense Genetics Innate 2.2 Factors relating to the physical environment 2.1 Biological and endogenous factors viruses human Aetiology dynein General Immunology and Microbiology General Neuroscience Prevention Inflammatory and immune system microbiology microtubule-based transport Immunity Dyneins viral antagonist viral protease General Medicine Immunity Innate Infectious Diseases Emerging Infectious Diseases Good Health and Well Being inflammation Viruses Biochemistry and Cell Biology Infection host–virus evolution |
Popis: | Viruses interact with the intracellular transport machinery to promote viral replication. Such host-virus interactions can drive host gene adaptation, leaving signatures of pathogen-driven evolution in host genomes. Here, we leverage these genetic signatures to identify the dynein activating adaptor, ninein-like (NINL), as a critical component in the antiviral innate immune response and as a target of viral antagonism. Unique among genes encoding components of active dynein complexes, NINL has evolved under recurrent positive (diversifying) selection, particularly in its carboxy-terminal cargo-binding region. Consistent with a role for NINL in host immunity, we demonstrate that NINL knockout cells exhibit an impaired response to interferon, resulting in increased permissiveness to viral replication. Moreover, we show that proteases encoded by diverse picornaviruses and coronaviruses cleave and disrupt NINL function in a host- and virus-specific manner. Our work reveals the importance of NINL in the antiviral response and the utility of using signatures of host-virus genetic conflicts to uncover new components of antiviral immunity and targets of viral antagonism.Humans and viruses are locked in an evolutionary arms race. Viruses hijack cells, using their resources and proteins to build more viral particles; the cells fight back, calling in the immune system to fend off the attack. Both actors must constantly and quickly evolve to keep up with each other. This genetic conflict has been happening for millions of years, and the indelible marks it has left on genes can serve to uncover exactly how viruses interact with the organisms they invade. One hotspot in this host-virus conflict is the complex network of molecules that help to move cargo inside a cell. This system transports elements of the immune system, but viruses can also harness it to make more of themselves. Scientists still know very little about how viruses and the intracellular transport machinery interact, and how this impacts viral replication and the immune response. Stevens et al. therefore set out to identify new interactions between viruses and the transport system by using clues left in host genomes by evolution. They focused on dynein, a core component of this machinery which helps to haul molecular actors across a cell. To do so, dynein relies on adaptor molecules such as 'Ninein-like', or NINL for short. Closely examining the gene sequence for NINL across primates highlighted an evolutionary signature characteristic of host-virus genetic conflicts; this suggests that the protein may be used by viruses to reproduce, or by cells to fend off infection. And indeed, human cells lacking the NINL gene were less able to defend themselves, allowing viruses to grow much faster than normal. Further work showed that NINL was important for a major type of antiviral immune response. As a potential means to sabotage this defence mechanism, some viruses cleave NINL at specific sites and disrupt its role in intracellular transport. Better antiviral treatments are needed to help humanity resist old foes and new threats alike. The work by Stevens et al. demonstrates how the information contained in host genomes can be leveraged to understand what drives susceptibility to an infection, and to pinpoint molecular actors which could become therapeutic targets. |
Databáze: | OpenAIRE |
Externí odkaz: |